287 results
Page 5 of 15
10-KT
EX-10.28
irsgiavla653
3 Mar 17
Annual report (with FYE transition)
12:00am
8-K
EX-10.4
ag2gqt08wrhihnyzl
13 Dec 16
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
su5nkr
13 Dec 16
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.3
a42h pj2v
13 Dec 16
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.5
po9c8l9
13 Dec 16
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.2
dqdoa2 hj5h
13 Dec 16
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
b65cmn b6bi8
29 Sep 16
ImmunoGen Completes Strategic Review to Strengthen the Organization and Drive Long-Term Growth
12:00am
8-K
EX-10.1
ezj7dj2p
17 Aug 16
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
u7q4te8
20 Jun 16
ImmunoGen Announces Pricing of $100 Million Offering of 4.50% Convertible Senior Notes Due 2021
12:00am
8-K
EX-10.1
aa9 mp8vjny6
26 Apr 16
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.2
cyzhwkocz42z8yo0
26 Apr 16
Departure of Directors or Certain Officers
12:00am